Lynx Dx Launches At-Home Prostate Cancer Test
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read MorePosted by Andy Lundin | Feb 3, 2025 | Prostate |
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Prostate, Urinalysis & Toxicology |
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Molecular Diagnostics, Prostate |
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Molecular Diagnostics, Prostate |
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read More